Affimed Therapeutics (AFMD) Priced

Biotech developing immunotherapies for lymphomas, leukemia and other cancers.

Health Care - Biotechnology

IPO Performance
Latest Trade $2.15 0.00 (0.0%)
First Day Return -18.6%
Return from IPO -69.3%
 
Affimed Therapeutics IPO News more
  • .
IPO Data
IPO File Date 06/27/2014
Offer Price $7.00
Price Range $11.00 - $13.00
Offer Shares (mm) 8.0
Deal Size ($mm) 56
 
IPO Data
IPO Date 09/11/2014
Offer Price $7.00
Price Range $11.00 - $13.00
Offer Shares (mm) 8.0
Deal Size ($mm) $56
 
Underwriters
more
Business Overview
Biotech developing immunotherapies for lymphomas, leukemia and other cancers.
Biotech developing immunotherapies for lymphomas, leukemia and other cancers.
more
Company Data
Headquarters Heidelberg, , Germany
Founded 2000
Employees 53
Website www.affimed.com
 

Performance vs. IPO Index (IPOUSA)